Theorem names VP, global business development

Thursday, October 27, 2011 12:22 PM

Theorem Clinical Research, previously Omnicare Clinical Research, has named Adam Serody vice president, global business development. In his new role, Serody will lead Theorem’s global sales, proposals and marketing organizations.

Most recently, Serody served as executive director of business development and global leader for phase IV at Pharmanet.

“His clinical background, proven sales track record, and expertise in driving marketing and proposals efforts provide Adam with a unique perspective on every aspect of not only the sales cycle, but also the clinical development cycle. With Adam leading our team, I believe we will be uniquely positioned for future success,” said John Potthoff, PhD, president and CEO of Theorem.

Share:          
CWWeekly

January 26

2015 CRO outlook: M&As, IPOs, strategic partnerships and increased eClinical outsourcing expected to continue

IOM, industry stakeholders propose standards, guidelines for open sharing of clinical trial data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs